Sofia, Bulgaria, September 9, 2024 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 5, 2024 the Company sold 6 770 (sixty thousand seven hundred and seventy) repurchased own shares representing 0.0038% of the share capital of the Company, at a total value of BGN 40 661,40 on the Bulgarian Stock Exchange, the average price per share was BGN 6,01.